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Intestinal fungi are an important component of the microbiota, and recent studies have unveiled their potential in modulating host immune homeostasis and inflammatory disease. Nonetheless, the mechanisms governing immunity to gut fungal communities (mycobiota) remain unknown. We identified CX3CR1 + mononuclear phagocytes (MNPs) as being essential for the initiation of innate and adaptive immune responses to intestinal fungi. CX3CR1 + MNPs express antifungal receptors and activate antifungal responses in a Syk-dependent manner. Genetic ablation of CX3CR1 + MNPs in mice led to changes in gut fungal communities and to severe colitis that was rescued by antifungal treatment. In Crohn's disease patients, a missense mutation in the gene encoding CX3CR1 was identified and found to be associated with impaired antifungal responses. These results unravel a role of CX3CR1 + MNPs in mediating interactions between intestinal mycobiota and host immunity at steady state and during inflammatory disease.
E
xtensive studies on intestinal bacteria have demonstrated that alterations in the microbiome have a dramatic impact on host immunity and contribute to several diseases of inflammatory origin. Fungi are present in the mammalian intestine (1) (2) (3) (4) (5) , yet little is known about their ability to influence immune homeostasis. Recent advances in deep sequencing technologies have redefined our understanding of fungal communities (mycobiota) colonizing mammalian barrier surfaces (2) . Intestinal fungal dysbiosis has been shown to influence colitis, alcoholic liver disease, and allergic lung disease (3-6), providing evidence for its potential to influence both local and distal inflammation. Moreover, serum antibodies against Saccharomyces cerevisiae mannan (ASCA) are elevated in several inflammatory diseases, including Crohn's disease (CD) (7) (8) (9) . Systemic ASCA can develop in response to intestinal fungi (3, 7) , providing a possible link between the gut mycobiota and host immunity. Despite the identification of receptors involved in the recognition and immunity to intestinal fungi (3, 10) , the cell subsets that initiate and regulate mucosal immune responses to the mycobiota remain unknown.
In the intestinal lamina propria (LP), several subsets of phagocytes respond to bacterial infections or to fluctuations in the commensal bacterial communities (11) (12) (13) . Among those, mononuclear phagocytes (MNPs), expressing the fractalkine receptor CX3CR1 (CX3CR1 + MNPs), and subsets of dendritic cells (DCs) marked by differential expression of the integrins CD11b and CD103 can initiate immunity and prime T helper 17 (T H 17) responses to both commensal and pathogenic bacteria in the gut (11, 12, 14) . Despite their well-described ability to respond to gut bacteria, their role in mucosal immunity to gut fungi remains unknown.
To assess the in vivo ability of gut resident phagocytes to respond to fungi, we colonized mice with the opportunistic human fungal commensal Candida albicans and analyzed the changes in the surface expression of the costimulatory molecules. We found that colonization with C. albicans altered the surface expression of CD40 and CD86 among CX3CR1 + MNPs but not among the other subsets ( fig. S1, A ) in the intestine. Bar graphs represent mean ± SEM of individual mice (n = 4 to 7 mice), representative of at least two independent experiments. *P < 0.05, **P < 0.01, one-way analysis of variance (ANOVA). (Fig. 1, A and B, and fig. S2A ) that have been shown to respond to lung fungal infection (14, 15 higher expression of genes involved in fungal recognition (Fig. 1B, and fig. S2B ). Quantitative polymerase chain reaction (PCR) and flow cytometric analysis confirmed that transcripts encoding the fungal C-type lectin receptors (CLRs) dectin-1 (Clec7a), dectin-2 (Clec6a), and mincle (Clec4e) were highly present in CX3CR1 + MNPs (Fig. 1 (12, 14, 16, 17) . CX3CR1 + MNPs are involved in the induction of T H 17 responses to intestinal bacteria (18) and are essential for the killing of Candida in the kidneys during systemic infection (19 (21, 22) . Upon colonization with C. albicans, we observed a strong T H 17 response in the colon and mesenteric lymph nodes (mLNs) that was consistent with other studies (Fig. 2, A and B, and fig. S5A ) (23) , whereas the frequency of Foxp3 + T reg cells was not affected (fig. S5B ). We next determined whether specific phagocytic subsets are involved in T H 17 responses to intestinal fungi. Candida colonization induced a consistent increase in T H 17 cell frequencies that were not affected by depletion of CD11b + CD103 + DCs (Fig. 2, A (Fig. 2, C and D, and fig. S6B ) but not in the small intestine ( fig. S7, A and B) . The observed T H 17 induction was independent from segmented filamentous bacteria (SFB) that were absent in our colony ( fig. S8, A to C) . Foxp3 + T reg cells were not affected by the absence of either phagocytic subset (figs. S5D, S6C, S7C, and S10, F and J).
Besides T H 17 responses, the development of systemic ASCA during intestinal inflammation is another hallmark of adaptive immunity activation in response to intestinal fungi (3, 7) . In addition to S. cerevisiae, Candida can act as an immunogen for ASCA production (7). Thus, we assessed whether lack of CX3CR1 + MNPs also alters the production of systemic immunoglobulin G (IgG) antibodies against the commensal fungus C. tropicalis (3) during steady state ( fig. S8D ). We found that CX3CR1 + MNPs depletion reduced IgG-antibody responses against C. tropicalis without affecting the response against the commensal bacterial antigen flagellin (Fig. 2E) . To assess whether the induction of antifungal IgG is dependent on fig. S9 ) without affecting the antibody production upon systemic infection (Fig. 2F) . This suggests that the defect in antifungal antibody production in DCX3CR1 mice is specific to the gut. By contrast, neither the depletion of CD11b + CD103
+ DCs nor the lack of CD11b -
CD103
+ DCs influenced systemic production of antibody to Candida (figs. S9 and S10K). Consistent with the decreased antifungal responses, C. albicans burdens are increased in DCX3CR1 mice but not in DIrf4 and Batf3 −/− mice ( Fig. 2G  and fig. S10L ).
To (Fig. 2H and fig.  S12 , C to E). CX3CR1 + MNPs might either directly transport fungal antigens to the mLNs for T cell priming or pass the antigens to other migratory phagocytes, although both scenarios are possible (11, 24) . Nevertheless, those data demonstrate that CX3CR1 + MNPs play an important role in the induction of T H 17 and antibody responses to intestinal fungi, whereas CD11b + CD103 + DCs and CD11b -CD103 + DCs are not crucial. Spleen tyrosine kinase (Syk) is crucial for the initiation of the signaling cascade downstream of several CLRs ( fig. S2 ) and is highly expressed in CX3CR1 + MNPs (Fig. 1, B and D, and fig S3B) . We thus generated DSyk CX3CR1 mice (Syk fl/fl x Cx3cr1-cre/ERT2 +/− ) to selectively delete Syk in CX3CR1 + cells ( fig. S13 ). Consistently, we observed fungal outgrowth but impaired T H 17 and antifungal antibody responses to intestinal Candida colonization (Fig. 2, I to L, and figs. S12F and S14), suggesting that intact CLR signaling in CX3CR1 + cells is required to control fungal colonization and to induce effective adaptive immunity to fungi in the gut.
Having determined that CX3CR1 + MNPs recognize intestinal fungi and control gut antifungal immunity, we explored whether these cells play a role in shaping the composition of gut fungal communities. We characterized the microbiota upon CX3CR1 + MNPs depletion using high-throughput internal transcribed spacer 1 and 16S sequencing of fungal and bacterial ribosomal DNA. Despite their role in the control of commensal and pathogenic bacteria (11, 16, 25) , ablation of CX3CR1 + MNPs did not affect b and a diversity of the intestinal bacterial community (figs. S15, A to E, and S16A). By contrast, ablation of CX3CR1 + MNPs, but not CD11b + CD103 + DCs, altered the fungal community composition of these mice as compared with control littermates (Fig. 3A and figs. S15B; S16, B to D; S17; and S18). CX3CR1 + MNPs depletion also led to an increase in fungal a-diversity that was mainly driven by an increased abundance and diversity among the Ascomycota phylum ( Fig. 3B and figs. S15, B and E, and S16, C and D). This suggests that CX3CR1 + MNPs play a role in immune surveillance and maintenance of a balanced gut fungal community.
Fungi are present at highest densities in the colon (3), where fungal colonization induced a strong T H 17 response (fig. S5A) . Thus, we next tested whether DCX3CR1 mice are more susceptible to dextran sulfate sodium (DSS)-induced colitis. Consistent with their inability to mount an efficient antifungal response, we found that DCX3CR1 mice were more susceptible to DSS colitis as compared with their littermate controls (Fig. 3, C and D, and fig. S19, A and B) . Fluconazole targets most Candida species and other dimorphic fungi and ameliorates colitis in mice with defects in antifungal immunity when used during the onset of intestinal disease (2, 3, 10) . Because CX3CR1 + MNPs depletion had a strong effect on Ascomycota, we treated DCX3CR1 mice with fluconazole. Fluconazole treatment ameliorated intestinal disease in DCX3CR1 mice (Fig. 3, C and D, and fig. S19 , A and B). Transfer of feces from DCX3CR1 mice did not affect the outcome of colitis in ex-germ-free mice (fig. S19, C to H), indicating that DCX3CR1 microbiota is not per se pathogenic. Further supplementation with C. tropicalis, previously shown to affect intestinal conditions in dectin-1-and dectin-3-deficient mice (3, 10, 26) , or with C. albicans led to severe wasting disease, colon shortening, and fungal overgrowth in the intestines of DCX3CR1 mice without worsening the disease in littermate controls (Fig. 3E and fig. S20,  A and B) . Despite the increased disease susceptibility and augmented Candida burden, DCX3CR1 mice failed to mount a systemic antifungal IgG antibody response (Fig. 3F and fig.  S20 , C and D), which is consistent with the defective antifungal immunity that we observed during the steady state. These results indicate that CX3CR1 + MNPs play a crucial role in controlling fungal microbiota during intestinal disease.
Having established a role for CX3CR1 + MNPs in the control of gut fungi during intestinal disease, and finding that CX3CR1 + MNPs have the potential to intake other species of mouse and human commensal fungi (Fig. 4A) affect immunity to fungi in inflammatory bowel disease (IBD). Defects in CX3CR1 have been shown to increase susceptibility of mice and humans to systemic candidiasis (19) but not to vulvovaginal and oral candidiasis (27) . By contrast, the role of CX3CR1 in the initiation of antifungal responses in the gut is unknown. We focused on polymorphisms in the coding region of the CX3CR1 gene ( fig. S21 ) that have been previously associated with human inflammatory diseases such as arteriosclerosis and coronary artery disease (28, 29) . Although none of these polymorphisms were associated with a predisposition to IBD (table S1) , we identified a striking association of CX3CR1 T280M (rs3732378) polymorphism specifically with IgG ASCA positivity in a cohort of 503 CD patients [odds ratio (OR) = 0.59, logistic regression P = 3.73 × 10
−03
] (Fig. 4B) . By contrast, antibodies against bacterial and host antigens previously shown to increase in IBD (7) were not affected by this mutation (Fig. 4B and  table S2 ). Because ASCA antibodies are directed against both S. cerevisiae and C. albicans (7), we next assessed whether antifungal antibody responses to common human commensals are also affected by CX3CR1 T280M. Compared with nonaffected individuals, patients homozygous for CX3CR1 T280M were severely impaired in their ability to generate systemic IgG recognizing a variety of gutrelevant fungi belonging to the phylum Ascomycota, while producing normal antibody responses against the bacterial antigen flagellin (Fig. 4, C and D, and  fig. S22 ), which is consistent with the hypothesis that this mutation in CX3CR1 leads to impaired responses to fungi in the gut.
We identified a specific subset of gut-resident phagocytes-namely, the CX3CR1 + MNPs-that are able to recognize and respond to the gut mycobiota in a Syk-dependent manner. CX3CR1 + MNPs can influence adaptive immune responses to gut fungi and control the mycobiota during experimental colitis. In humans, we found that a CX3CR1 polymorphism is strongly associated with a decrease of antifungal antibody responses in CD patients. CX3CR1 T280M is a common polymorphism [23.3% heterozygous and 4.4% homozygous (30) ] and has been previously associated with extraintestinal inflammatory diseases (28, 29) . Conceivably, gut mycobiota and CX3CR1-dependent immune responses might further contribute to extraintestinal manifestations of inflammatory diseases. In support of this notion, antifungal antibodies are increased in patients with alcoholic liver disease, spondyloarthritis, Graves' disease, and systemic lupus erythematosus (6) (7) (8) (9) . Altogether, our findings provide evidence for the influence of gut fungal communities on both local and systemic immunity, which is mediated by the recognition of intestinal fungi by CX3CR1 + MNPs.
